Onc Med Chem FINAL
Help!
|
|
|
|
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Chlorambucil | Reactive species - aziridinium ion; DNA alkylation | PO
🗑
|
|||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Cyclophosphamide | Urotoxicity; Nephrotoxicity | Hemorrhagic cystitis managed by hydration, Mesna
🗑
|
|||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Ifosfamide | Urotoxicity; Nephrotoxicity to a greater extent | Hemorrhagic cystitis managed by hydration, Mesna
🗑
|
|||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Carmustine | DNA alkylation | Prolonged myelosuppression | High lipid solubility
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Lomustine | DNA alkylation | Prolonged myelosuppression | High lipid solubility
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Busulfan | DNA alkylation | Skin hyper-pigmentation (Busulfan tan); Pulmonary fibrosis; adrenal insufficiency |
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Procarbazine | DNA methylation | Myelosuppression |
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Dacarbazine | DNA methylation | Myelosuppression |
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Cisplatin | Intra-strand DNA cross-linking (active form generated by reaction with water) | Nephrotoxicity, Ototoxicity | Manage nephrotoxicity by pre-and post-hydration with normal saline
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Carboplatin | Intra-strand DNA cross-linking (active form generated by reaction with water) | Myelosuppression |
🗑
|
||||||||||
| DNA Crosslinking Agents (Inhibit DNA synthesis and function) (Cell cycle phase non-specific) | Oxaliplatin | Intra-strand DNA cross-linking (active form generated by reaction with water) | Peripheral neuropathy |
🗑
|
||||||||||
| Antitumor Antibiotics (Cell cycle phase non-specific) | Anthracyclines: Doxorubicin, Duanorubicin; Idarubicin; Epirubicin; Valrubicin | Inhibition of Topoisomerase IIα; Allow DNA nicking but prevent DNA religation | Cardiotoxicity (acute-ROS related; chronic-rubicinol related) | Colors urine red
🗑
|
||||||||||
| Antitumor Antibiotics (Cell cycle phase non-specific) | Bleomycin | Free radical mediated DNA strand breaks | Pulmonary fibrosis, Skin toxicity | No myelosuppression; Drug inactivation by bleomycin hydrase
🗑
|
||||||||||
| Mitotic Inhibitors (Cell cycle M-phase specific) | Vincristine | Inhibit microtubule polymerization | Neurotoxicity |
🗑
|
||||||||||
| Mitotic Inhibitors (Cell cycle M-phase specific) | Vinblastine | Inhibit microtubule polymerization | Myelosuppression |
🗑
|
||||||||||
| Mitotic Inhibitors (Cell cycle M-phase specific) | Vinorelbine | Inhibit microtubule polymerization | Myelosuppression |
🗑
|
||||||||||
| Mitotic Inhibitors (Cell cycle M-phase specific) | Paclitaxel | Inhibit microtubule depolymerization | Peripheral neuropathy | Hypersensitivity rxn (pre-treat patient w/ dexamethasone, H1 antagonists.
🗑
|
||||||||||
| Mitotic Inhibitors (Cell cycle M-phase specific) | Docetaxel | Inhibit microtubule depolymerization | Fluid retention, Peripheral Neuropathy, Myelosuppression w/ neutropenia | Hypersensitivity rxn (pre-treat patient w/ dexamethasone, H1 antagonists.
🗑
|
||||||||||
| Topoisomerase Inhibitors (Interfere with nicked DNA resealing) (Cell cycle S-phase specific) | Topotecan | Inhibit topoisomerase I | Myelosuppression |
🗑
|
||||||||||
| Topoisomerase Inhibitors (Interfere with nicked DNA resealing) (Cell cycle S-phase specific) | Irinotecan | Inhibit topoisomerase I | Acute and delayed diarrhea | SN-38 is the active drug; UGT1A1*28/*6 homo-or heterozygotes will have reduced irinotecan metabolism, hence increased toxicity
🗑
|
||||||||||
| Topoisomerase Inhibitors (Interfere with nicked DNA resealing) (Cell cycle S-phase specific) | Etoposide | Inhibit topoisomerase II | Myelosuppression |
🗑
|
||||||||||
| Topoisomerase Inhibitors (Interfere with nicked DNA resealing) (Cell cycle S-phase specific) | Teniposide | Inhibit topoisomerase II |
🗑
|
|||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | 5-Fluorouracil (5-FU) | Direct Inhibition of thymidylate synthase | Myelosuppression, Hand and foot syndrome, mucositis, neurotoxicity | 5-FdUMP is the active form; Metabolic inactivation by dihydropyrimidine dehydrogenase; Leucovorin enhances drug activity
🗑
|
||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | Capecitabine | Direct Inhibition of thymidylate synthase | Myelosuppression, Hand and foot syndrome, mucositis, neurotoxicity | 5-FdUMP is the active form; Metabolic inactivation by dihydropyrimidine dehydrogenase; Leucovorin enhances drug activity
🗑
|
||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | Methotrexate | Inhibits DHFR Inhibits purine biosynthesis | Myelosuppression, mucositis, diarrhea | Leucovorin rescue to mitigate drug toxicity
🗑
|
||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | Pemetrexed | Inhibits DHFR Inhibits purine biosynthesis |
🗑
|
|||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | 6-Mercaptopurine | Inhibits purine biosynthesis by inhibiting amidophosphoribosyltransferase | Myelosuppression | PO available; Bioactivated by HGPRT;
🗑
|
||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | 6-Thioguanine | Inhibits purine biosynthesis by inhibiting amidophosphoribosyltransferase | Myelosuppression | PO available; Bioactivated by HGPRT;
🗑
|
||||||||||
| Anitmetabolites (Mimic physiologic biomolecules) (Cell cycle S-phase specific) | Cytarabine, Gemcitabine, Cladribine, Fludarabine | Inhibits DNA synthesis and repair (inhibit DNA polymerase by competing with normal nucleotides); Inhibits DNA chain elongation (by inserting at 3’ end) | Myelosuppression |
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
KaylaHaase